Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
19-21 November, 2024
Not Confirmed
Not Confirmed
19-21 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
19-21 November, 2024
Industry Trade Show
Not Confirmed
19-21 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/medical-breakthroughs-in-2024-alzheimer-s-schizophrenia-copd-mash-see-pathbreaking-treatments
05 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/05/2974868/0/en/Insignis-Therapeutics-Receives-Positive-FDA-Feedback-on-IN-001-Clinical-Program-for-Needle-Free-Anaphylaxis-Treatment.html
07 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/07/2958883/0/en/Insignis-Therapeutics-Announces-Positive-Results-from-Phase-1-Clinical-Study-of-IN-001-Liquid-Epinephrine-Sublingual-Spray-for-Anaphylaxis.html
13 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/13/2929089/0/en/Insignis-Therapeutics-Receives-FDA-Fast-Track-Designation-for-IN-001-for-Anaphylaxis-Treatment.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?